{"id":"W4417016071","doi":"10.1182/blood-2025-724","title":"A comparison of real-world outcomes of asciminib versus ATP-competitive tyrosine kinase inhibitors as second-line treatment in patients with chronic myeloid leukemia in chronic phase","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Myeloid leukemia; Comorbidity; Dasatinib; Tyrosine-kinase inhibitor; Retrospective cohort study; Sorafenib; Imatinib mesylate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002889223,0.0002483622,0.0004626316,0.0009625619,0.0003675953,0.001056384,0.000413377,0.0004571656,0.001877388],"category_scores_gemma":[0.008681208,0.0001633588,0.0008907868,0.00116304,0.00035775,0.0009771512,0.0006983332,0.0005630839,0.0002968506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001292922,"about_ca_system_score_gemma":0.000579011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001785804,"about_ca_topic_score_gemma":0.002379531,"domain_scores_codex":[0.9968078,0.001233498,0.0004942409,0.00074544,0.0004629032,0.0002560972],"domain_scores_gemma":[0.9873748,0.002468328,0.008078615,0.000399653,0.000965213,0.0007133655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00575663,0.0002510436,0.9861085,0.0001292541,0.0006612531,0.00007843159,0.0001288863,0.0004890413,0.0002024141,0.0001236246,0.0007900141,0.005281075],"study_design_scores_gemma":[0.0003619417,0.004159522,0.9906499,0.00007563517,0.000337272,0.0003551438,0.0004121597,0.001572531,0.000327,0.0001105274,0.001609146,0.00002926495],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949799,0.0006473851,0.0001747067,0.00008423339,0.00001944863,0.00009920179,0.003190873,0.000004861435,0.0007993099],"genre_scores_gemma":[0.9967848,0.0001313792,0.000112874,0.00004555333,0.00002275933,0.00008539719,0.002723439,0.000002073702,0.00009170549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002889223,"threshold_uncertainty_score":0.01527983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01838019164653806,"score_gpt":0.3251358163633259,"score_spread":0.3067556247167879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}